Quotient discloses underwritten public offering price
June 24, 2022 -- Commercial-stage diagnostics company Quotient recently disclosed the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of $20.0 million. Read More
OpGen touts study on Unyvero pneumonia panel
June 24, 2022 -- OpGen is promoting a study showing that the company’s Unyvero hospitalized pneumonia panel detects potential pneumonia pathogens early, the results published June 22 in the European Journal of Clinical Microbiology & Infectious Diseases. Read More
Nanomix launches trial of eLab analyzer and panel
June 23, 2022 -- Nanomix has launched a trial in Spain to evaluate its eLab mobile immunoassay diagnostic system and S1 Panel assay for the detection of critical infections. Read More
Eurofins develops monkeypox PCR assay
June 23, 2022 -- Eurofins Technologies has developed a new multiplex real-time polymerase chain reaction (RT-PCR) assay for the detection of the monkeypox virus and its differentiation from other orthopoxviruses. Read More
Pictor receives CE Mark for COVID-19 test
June 23, 2022 -- Pictor has received Europe's CE Mark for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test. Read More
Wearable device, algorithm show early detection promise
June 22, 2022 -- A wearable tracking tool and machine learning algorithm could augment molecular testing for COVID-19 and other conditions and provide an early warning that an infection is on the way before symptoms begin, according to a new study. Read More
Eurofins raises 600M euros in public bond issue
June 21, 2022 -- Bioanalytical testing firm Eurofins Scientific on Tuesday announced it has raised 600 million euros ($632.1 million) in a senior, unsecured public bond issue. Read More
Oxford BioDynamics launching oncology test in the U.K.
June 21, 2022 -- Oxford BioDynamics on Tuesday announced that its Checkpoint inhibitor Response Test (CiRT) is now available to private physicians considering immune checkpoint inhibitor (ICI) therapy for patients in the U.K. Read More
Blood grouping, typing market estimated at $945 million
June 17, 2022 -- In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. Read More
Nonagen Bioscience secures CE Mark for bladder cancer test
June 17, 2022 -- Nonagen Bioscience has secured the CE Mark for its bladder cancer immunoassay, Oncuria, enabling it to sell the test in the European Union. Read More
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current